NCT00164281View on ClinicalTrials.gov

Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana

PHASE4CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

May 31, 2011

Conditions
TuberculosisHIV Infections
Interventions
DRUG

Isoniazid

Daily 300 mg isoniazid supplemented with 25 mg pyridoxine for 6 months vs 36 months.

Trial Locations (1)

Unknown

Gaborone and Francistown Health Clinics, Gaborone and Francistown

All Listed Sponsors
collaborator

Botswana Ministry of Health

OTHER_GOV

collaborator

United States Agency for International Development (USAID)

FED

lead

Centers for Disease Control and Prevention

FED

NCT00164281 - Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana | Biotech Hunter | Biotech Hunter